10 Year Financial Data of Abbott Laboratories (ABT)

37.81 (1y: +27%)

Market Cap	59.33 B	P/E(ttm)	11.60
Enterprise Value	56 B	P/B	2.20

ABT- NYSE (USA)
Abbott Laboratories

Currently 3.5/5

Business Predictability Rank: 3.5-Star
Back Testing Results:
Average gain of all 3.5-Star stocks: 9.3% per year.
% of Stocks that are in still loss if held for 10yrs: 9%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$37.81

1 Severe Warning Sign 5 Medium Warning Signs 1 Good Sign

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	9.1	8.1	-9.8
EBITDA Growth (%)	10.3	7.6	4.5
Free Cash Flow Growth (%)	13.7	5.8	-23.1
Book Value Growth (%)	8.7	9	-11.1

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	12.52	12.53	14.28	14.63	16.61	18.92	19.89	22.60	24.79	25.05	22.49	5.95	6.17	6.13	6.80	3.39
EBITDA per Share	2.92	3.30	3.66	2.34	4.12	4.83	5.38	5.60	5.61	6.83	6.01	1.46	1.76	1.72	1.88	0.65
Free Cashflow per Share	1.59	1.98	2.54	2.60	2.26	3.88	4.00	4.96	4.77	4.72	3.72	1.11	1.03	1.87	0.70	0.12
Earnings per Share ($)	1.75	2.06	2.16	1.12	2.31	3.12	3.69	2.96	3.01	3.72	3.29	0.78	1.08	1.21	0.66	0.34
Dividends Per Share	0.97	1.03	1.09	1.16	1.27	1.41	1.56	1.72	1.88	2.01	1.67	0.48	0.51	0.51	0.51	0.14
Book Value per Share	8.32	9.12	9.22	9.15	11.40	11.20	14.77	14.39	15.59	16.79	14.24	16.01	15.42	16.94	16.76	14.24
Month End Stock Price	20.95	22.32	18.87	23.31	26.87	25.54	25.83	22.92	26.91	31.34	35.32	29.33	30.85	32.80	31.34	35.32
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	21.10	22.60	23.40	12.20	20.30	27.90	25.10	20.70	19.30	22.30	9.60	19.60	28.00	28.80	15.60	9.60
Return on Assets %	10.30	11.20	11.60	4.70	9.10	11.50	11.00	7.80	7.80	8.90	5.20	8.00	11.20	12.40	6.40	5.20
Return on Capital - Joel Greenblatt %	32.60	39.60	48.00	19.80	37.00	55.20	47.50	43.60	50.30	60.70	25.60	52.40	70.00	68.40	72.40	25.60
Debt to Equity	0.46	0.47	0.46	0.88	0.69	0.66	0.72	0.85	0.63	0.77	0.31	0.65	0.74	0.60	0.77	0.31

Gross Margin %	51.90	54.90	52.40	56.30	55.90	57.30	57.10	58.30	60.00	62.10	54.80	60.60	62.90	62.20	62.50	54.80
Operating Margin %	16.90	19.80	19.50	9.10	17.70	19.30	20.30	17.30	14.80	20.30	11.40	16.70	21.50	20.40	22.30	11.40
Net Margin %	14.00	16.40	15.10	7.60	13.90	16.50	18.70	13.20	12.20	15.00	10.10	13.10	17.60	19.90	9.70	10.10

Days Sales Outstanding	61.50	68.60	58.40	68.70	69.70	67.60	77.60	74.60	72.20	69.70	66.30	73.70	62.80	64.70	63.90	66.30
Days Inventory	106	108	87.20	104	94.30	80.30	90.20	79.40	77.10	91.50	101	86.70	88.00	93.90	85.00	101
Inventory Turnover	3.50	3.40	4.20	3.50	3.90	4.50	4.00	4.60	4.70	4.00	0.90	1.00	1.00	1.00	1.10	0.90

Debt to Revenue	0.30	0.35	0.30	0.55	0.47	0.39	0.54	0.54	0.40	0.51	1.32	1.76	1.84	1.67	1.89	1.32
COGS to Revenue	0.48	0.45	0.48	0.44	0.44	0.43	0.43	0.42	0.40	0.38	0.45	0.39	0.37	0.38	0.37	0.45
Inventory to Revenue	0.14	0.13	0.11	0.13	0.11	0.09	0.11	0.09	0.09	0.10	0.50	0.38	0.36	0.39	0.35	0.50
Interest Exp. to Revenue %	-0.74	-0.76	-0.69	-1.30	-1.76	-1.11	-1.24	-1.27	-1.15	-1.29	-0.48	-1.16	-1.09	-1.37	-1.51	-0.48

Asset Turnover	0.74	0.68	0.77	0.62	0.65	0.70	0.59	0.59	0.65	0.59	0.13	0.15	0.16	0.15	0.16	0.13
Buyback Ratio	-2.70	-4.90	-6.60	-29.30	-34.70	--	--	--	--	--	--	--	--	--	--	--
Dividend Payout Ratio	0.55	0.50	0.50	1.04	0.55	0.45	0.42	0.58	0.62	0.54	0.41	0.61	0.47	0.42	0.77	0.41
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	19,681	19,680	22,338	22,476	25,914	29,528	30,765	35,167	38,851	39,874	35,795	9,457	9,807	9,773	10,837	5,378
Cost of Goods Sold	9,473	8,884	10,641	9,815	11,422	12,612	13,209	14,665	15,541	15,120	13,827	3,725	3,637	3,698	4,059	2,432
Gross Profit	10,207	10,796	11,697	12,661	14,492	16,916	17,555	20,502	23,311	24,754	21,969	5,732	6,170	6,075	6,778	2,946

Selling, General, &Admin. Expense	5,051	4,922	5,496	6,350	7,408	8,436	8,406	10,376	12,757	12,059	10,845	3,000	2,944	2,922	3,193	1,786
Research &Development	1,733	1,697	1,821	2,255	2,506	2,689	2,744	4,038	4,129	4,322	3,663	1,006	1,011	1,164	1,141	346
Earnings Before DDA	4,597	5,187	5,721	3,601	6,433	7,533	8,325	8,712	8,796	10,868	9,584	2,319	2,796	2,749	3,004	1,036

Depreciation, Depletion and Amortization	1,274	1,289	1,359	1,559	1,855	1,839	2,090	2,624	3,044	2,783	2,461	743	691	760	589	421

Operating Income	3,323	3,898	4,362	2,042	4,579	5,694	6,236	6,088	5,752	8,085	7,124	1,576	2,104	1,989	2,415	615
Interest Income/Expense	-146	-149	-154	-292	-456	-327	-382	-448	-445	-513	-429	-109	-107	-134	-163	-25.71
Net Income	2,753	3,236	3,372	1,717	3,606	4,881	5,746	4,626	4,728	5,963	5,265	1,242	1,725	1,943	1,053	545

Earnings per Share ($)	1.75	2.06	2.16	1.12	2.31	3.12	3.69	2.96	3.01	3.72	3.29	0.78	1.08	1.21	0.66	0.34
Total Shares Outstanding	1,572	1,571	1,564	1,537	1,560	1,561	1,547	1,556	1,567	1,592	1,586	1,590	1,589	1,594	1,594	1,586
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	1,286	2,059	2,956	1,373	2,821	5,080	9,932	5,451	8,097	15,174	8,517	9,527	11,002	11,505	15,174	8,517
Accounts Receivable	3,313	3,696	3,577	4,231	4,947	5,466	6,542	7,184	7,684	7,613	3,918	7,660	6,768	6,949	7,613	3,918
Inventory	2,738	2,620	2,542	2,806	2,951	2,776	3,265	3,189	3,284	3,792	2,710	3,549	3,518	3,814	3,792	2,710
Other Current Assets	2,952	2,359	2,311	2,871	3,324	3,721	3,575	6,493	4,703	4,743	3,951	4,866	4,969	4,997	4,743	3,951
Total Current Assets	10,290	10,734	11,386	11,282	14,043	17,043	23,314	22,318	23,769	31,323	19,097	25,602	26,257	27,264	31,323	19,097

Property, Plant and Equipment	6,282	6,008	6,003	6,946	7,518	7,219	7,619	7,971	7,874	8,063	5,791	7,955	7,831	7,961	8,063	5,791
Intangible Assets	8,539	10,857	9,961	15,853	15,849	15,138	19,492	28,082	25,695	24,362	15,482	25,696	24,340	24,669	24,362	15,482
Other Long Term Assets	1,604	1,168	1,791	2,097	2,304	3,019	1,991	1,092	2,939	3,487	2,316	3,163	3,431	3,364	3,487	2,316
Total Assets	26,715	28,767	29,141	36,178	39,714	42,419	52,417	59,462	60,277	67,235	42,687	62,416	61,860	63,258	67,235	42,687

Accounts Payable	3,934	3,546	3,755	5,026	4,933	7,944	7,824	10,868	12,105	10,890	6,501	12,000	11,038	12,061	10,890	6,501
Current Portion of Long-Term Debt	2,537	1,993	2,062	5,401	2,726	2,732	5,190	6,395	3,375	2,391	3,636	4,785	6,083	4,225	2,391	3,636
Other Current Liabilities	1,168	1,287	1,598	1,524	1,445	916	36.10	0.00	-0.00	--	270	-0.00	0.00	--	--	270
Total Current Liabilities	7,640	6,826	7,416	11,951	9,103	11,592	13,049	17,262	15,480	13,280	10,406	16,786	17,120	16,286	13,280	10,406

Long-Term Debt	3,452	4,788	4,572	7,010	9,488	8,713	11,266	12,524	12,040	18,085	3,467	11,862	12,004	12,055	18,085	3,467
Other Long-Term Liabilities	2,551	2,828	2,739	3,163	3,344	4,634	5,245	7,288	8,317	9,149	6,226	8,315	8,248	7,903	9,149	6,226
Total Liabilities	13,643	14,442	14,726	22,124	21,935	24,940	29,561	37,074	35,837	40,514	20,098	36,962	37,373	36,244	40,514	20,098

Common Stock	3,034	3,240	3,524	--	--	--	--	--	--	11,755	11,615	10,378	10,815	--	11,755	11,615
Retained Earnings	9,691	10,033	10,405	9,569	10,806	13,825	17,054	18,927	20,907	24,151	20,062	21,314	22,228	23,327	24,151	20,062
Additional Paid-In Capital	--	--	--	4,291	6,104	7,444	8,258	8,745	9,817	--	--	--	--	11,419	--	--
Treasury Stock	-230	-221	-212	-195	-1,213	-2,626	-3,310	-3,917	-3,687	-5,591	-6,195	-4,298	-5,013	-4,975	-5,591	-6,195
Total Equity	13,072	14,326	14,415	14,054	17,779	17,480	22,856	22,388	24,440	26,721	22,588	25,454	24,487	27,014	26,721	22,588
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	2,753	3,176	3,372	1,717	3,606	4,881	5,746	4,626	4,728	5,963	5,265	1,242	1,725	1,943	1,053	545
Depreciation, Depletion and Amortization	1,274	1,289	1,359	1,559	1,855	1,839	2,090	2,624	3,044	2,783	2,461	743	691	760	589	421
Cash Flow from Discontinued Operations	--	--	--	--	--	350	--	--	--	--	--	--	--	--	--	--
Cash Flow from Others	-281	-56.59	443	2,054	-277	275	-560	1,486	1,198	568	-177	240	-349	817	-139	-505
Cash Flow from Operations	3,746	4,408	5,174	5,329	5,184	7,344	7,275	8,736	8,970	9,314	7,550	2,225	2,067	3,520	1,503	460

Investment for Property, Plant & Equipement	-1,247	-1,292	-1,207	-1,338	-1,656	-1,288	-1,089	-1,015	-1,492	-1,795	-1,616	-453	-425	-531	-386	-274
Cash Flow from Acquisitions	-498	-2,328	-295	-7,923	--	-250	-2,371	-9,433	-673	-1,227	-557	-671	-110	-422	-25.00	--
Cash Flow from Investing	-1,631	-3,923	-720	-11,398	-1,136	-2,087	-3,699	-12,188	261	-6,081	-3,177	-5,013	688	-532	-1,225	-2,108

Net Issuance of Stock	-22.58	-345	-1,079	-252	191	-1,082	-826	-867	-77.01	-2,364	-2,302	-988	-734	-1.23	-641	-925
Net Issuance of Debt	-468	806	173	5,651	-544	-1,239	3,734	2,122	-3,977	4,413	5,316	1,345	1,298	-1,908	3,678	2,249
Cash Flow for Dividends	-1,516	-1,600	-1,686	-1,777	-1,959	-2,174	-2,414	-2,671	-2,938	-3,183	-2,648	-759	-807	-805	-812	-224
Other Financing	0.00	700	--	0.00	--	1,009	509	328	969	1,850	-4,669	687	359	524	280	-5,832
Cash Flow from Financing	-2,006	-438	-2,592	3,622	-2,313	-3,486	1,002	-1,088	-6,023	716	-4,303	286	115	-2,191	2,506	-4,733

Net Change in Cash	291	231	1,668	-2,372	1,935	1,656	4,697	-5,161	3,164	3,989	27.21	-2,467	2,707	944	2,805	-6,429

Free Cash Flow	2,500	3,116	3,967	3,991	3,528	6,056	6,186	7,721	7,479	7,519	5,933	1,772	1,642	2,989	1,117	186
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

ABT Quarterly/Annuals Reports

ABT: 10-Q - ABBOTT LABORATORIES (0000001800) (Filer): (10-Q) - 2012-11-07
ABT: 10-Q - ABBOTT LABORATORIES (0000001800) (Filer): (10-Q) - 2012-08-07
ABT: 10-Q - ABBOTT LABORATORIES (0000001800) (Filer): (10-Q) - 2012-05-08
ABT: 10-K - ABBOTT LABORATORIES (0000001800) (Filer): (10-K) - 2012-02-21
ABT: 10-Q - ABBOTT LABORATORIES (0000001800) (Filer): (10-Q) - 2011-11-04

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

ABT Quarterly/Annuals Reports